Transforming growth factor-beta (TGF1) enhances human MDA-MB-231 breast tumour cell invasion of reconstituted basement membrane in vitro but does not inhibit proliferation of this cell line. In contrast to basal invasion, which is plasmin-, urokinase (uPA)-, tissue-type plasminogen activator (t-PA)
Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-β1
✍ Scribed by Xiaoming Lu; Jun Liu; Hang Li; Wei Li; Xuesong Wang; Jingwei Ma; Qiang Tong; Ke Wu; Guobin Wang
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 314 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background and Objectives
Regulatory T cells (Treg) inhibits immune responses mediated by T cells. This study aimed to investigate whether Treg are accumulated in human gastric cancer tissue and the mechanism of Treg induction by gastric cancer cells.
Methods
Tissue infiltrated leukocytes from gastric adenocarcinomas were subjected to flow cytometry and immunohistochemistry. Percentage, phenotype, function, and clinical relevance of Treg were analyzed. TGF‐β1 production by cancer cells was determined by Western blot and in vitro co‐culture experiments were performed to mimic gastric cancer microenvironment.
Results
The percentages of CD4^+^Foxp3^+^ T cells in gastric cancer tissues were significantly higher than those from adjacent non‐tumor gastric tissues (P < 0.05). The results of classical Treg phenotype and proliferation assay supported that the elevated CD4^+^Foxp3^+^ T cells represents a suppressive Treg population. High proportion of Treg is correlated to advance TNM stage and reduced survival. Primary gastric cancer cells produced abundance of TGF‐β1 which was responsible for conversion of Treg.
Conclusion
The proportion of functional Treg is elevated in human gastric cancer and related to poor prognosis. Gastric cancer cells directly convert CD4^+^ naive T cells to Treg by TGF‐β1, suggesting a possible mechanism through which tumor cells evade the immune system. J. Surg. Oncol. 2011; 104:571–577. © 2011 Wiley Periodicals, Inc.
📜 SIMILAR VOLUMES
Swiss 3T3 mouse fibroblasts were exposed to 10 microM colchicine to disrupt microtubules, then stimulated with insulin-like growth factor-I. Immunoprecipitation experiments showed that insulin-like growth factor-I receptor and insulin receptor substrate-1 were tyrosine phosphorylated to the same ext